Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Reference31 articles.
1. Schioppo T, Ingegnoli F (2017) Current perspective on rituximab in rheumatic diseases. Drug Des Devel Ther 11:2891–2904
2. Berghen N, Vulsteke JB, Westhovens R, Lenaerts J, De Langhe E (2019) Rituximab in systemic autoimmune rheumatic diseases: indications and practical use. Acta Clin Belg 74(4):272–279
3. Genentech Inc. Rituxan (rituximab): US prescribing information (2019) Available from: https://www.gene.com/download/pdf/rituxan_prescribing.pdf. Accessed 31 Dec 2021
4. Cohen HP, Blauvelt A, Rifkin RM, Danese S, Gokhale SB, Woollett G (2018) Switching reference medicines to biosimilars: a systematic literature review of clinical outcomes. Drugs 78(4):463–478
5. Dorner T, Strand V, Cornes P, Goncalves J, Gulacsi L, Kay J et al (2016) The changing landscape of biosimilars in rheumatology. Ann Rheum Dis 75(6):974–982